For: | Wu HHL, Rakisheva A, Ponnusamy A, Chinnadurai R. Hepatocardiorenal syndrome in liver cirrhosis: Recognition of a new entity? World J Gastroenterol 2024; 30(2): 128-136 [PMID: 38312119 DOI: 10.3748/wjg.v30.i2.128] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v30/i2/128.htm |
Number | Citing Articles |
1 |
V. L. Korobka, Yu. V. Khoronko, R. V. Korobka, E. V. Kosovtsev, M. V. Malevanny, E. S. Pak, E. V. Tadieva. Transjugular intrahepatic portosystemic shunting in patients over 60 years with cirrhosis and comorbidities when liver transplantation is reasonably denied. Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery 2024; 29(3): 40 doi: 10.16931/31/1995-5464.2024-3-40-49
|
2 |
Shihao Zheng, Chengyuan Xue, Size Li, Xiaobin Zao, Xiaoke Li, Qiyao Liu, Xu Cao, Wei Wang, Wenying Qi, Hongbo Du, Peng Zhang, Yongan Ye. Liver cirrhosis: current status and treatment options using western or traditional Chinese medicine. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1381476
|
3 |
Ramadan A. Saad, Mai Tarek, Howaida S. Ali, Wael M. Elayat, Abd El-Hamid A. Mohamed. Vitamin D3 Ameliorates BDL-Induced Hepatocardiac Abnormalities. Possible Role of IGF-1. Journal of Evolutionary Biochemistry and Physiology 2025; 61(1): 327 doi: 10.1134/S0022093024600519
|
4 |
Dae Gon Ryu, Fengxue Yu, Ki Tae Yoon, Hongqun Liu, Samuel S. Lee. The Cardiomyocyte in Cirrhosis: Pathogenic Mechanisms Underlying Cirrhotic Cardiomyopathy. Reviews in Cardiovascular Medicine 2024; 25(12) doi: 10.31083/j.rcm2512457
|
5 |
Andrzej S Tarnawski. Editor-in-Chief articles of choice and comments from January to June 2024. World Journal of Gastroenterology 2024; 30(34): 3875-3882 doi: 10.3748/wjg.v30.i34.3875
|